Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus

Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus

Background Prospective comparative studies on the effects of various antidiabetic agents on bone metabolism are limited. This study aimed to assess changes in bone mass and biochemical bone markers in postmenopausal patients with type 2 diabetes mellitus (T2DM). Methods This prospective, multicenter...

Full description

Bibliographic Details
Main Authors:	Jeonghoon Ha, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Seung Hyun Ko, Moo Il Kang, Sung Dae Moon, Ki-Hyun Baek
Format:	Article
Language:	English
Published:	Korean Endocrine Society 2021-08-01
Series:	Endocrinology and Metabolism
Subjects:	osteoporosis diabetes mellitus bone density thiazolidinediones sodium-glucose transporter 2 inhibitors
Online Access:	http://www.e-enm.org/upload/pdf/enm-2021-1026.pdf

Similar Items

The efficacy of denosumab in Korean male patients with osteoporosis
by: Chaiho Jeong, et al.
Published: (2022-09-01)

Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus
by: Seung Eun Lee, et al.
Published: (2022-07-01)

Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study
by: Chaiho Jeong, et al.
Published: (2023-04-01)

Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?
by: Ki Dong Ko, et al.
Published: (2017-06-01)

The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition
by: Yu Seol Lee, et al.
Published: (2018-09-01)

Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent
by: Manal Y. Sameeh, et al.
Published: (2021-12-01)

Effects of Sodium-Glucose Cotransporter-2 Inhibitors and Thiazolidinedione on New-Onset Atrial Fibrillation Risk to Patients with Type 2 Diabetes
by: Haegeun Song, et al.
Published: (2022-09-01)

Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice
by: Kyoung Min Kim, et al.
Published: (2017-09-01)

Antimicrobial screening of new 5-(chromene-3-yl) methylene-2,4-thiazolidinediones
by: Cristina Nastasă, et al.
Published: (2015-08-01)

Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea
by: Chaiho Jeong, et al.
Published: (2023-11-01)

Comparison of the Effects of Metformin and Thiazolidinediones on Bone Metabolism: A Systematic Review and Meta-Analysis
by: Ru-Dong Chen, et al.
Published: (2023-05-01)

The Effect of Diabetes Mellitus, Insulin, and Thiazolidinediones on Bone Histomorphometry in Streptozotocin-induced Diabetic Postmenopausal Wistar Rats
by: Derya Köseoğlu, et al.
Published: (2021-03-01)

Discovery of Novel Thiazolidinedione-Derivatives with Multi-Modal Antidiabetic Activities In Vitro and In Silico
by: Charles Arineitwe, et al.
Published: (2023-02-01)

Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial
by: Jinyoung Kim, et al.
Published: (2022-04-01)

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
by: Jong Ho Kim, et al.
Published: (2016-04-01)

New Succinimide–Thiazolidinedione Hybrids as Multitarget Antidiabetic Agents: Design, Synthesis, Bioevaluation, and Molecular Modelling Studies
by: Mohammed A. Huneif, et al.
Published: (2023-01-01)

Pioglitazone Reverses Markers of Islet Beta-Cell De-Differentiation in <i>db/db</i> Mice While Modulating Expression of Genes Controlling Inflammation and Browning in White Adipose Tissue from Insulin-Resistant Mice and Humans
by: J. Jason Collier, et al.
Published: (2021-09-01)

Efficacy and safety of pioglitazone plus phototherapy versus phototherapy in patients with plaque type psoriasis: a Double Blinded Randomized Controlled Trial
by: Maryam Ghiasi, et al.
Published: (2019-10-01)

Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action
by: Graziella Bruno, et al.
Published: (2010-09-01)

Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
by: Mariusz Dąbrowski
Published: (2021-02-01)

A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus
by: Bo-Yeon Kim, et al.
Published: (2022-11-01)

Cancer Biology and Prevention in Diabetes
by: Swayam Prakash Srivastava, et al.
Published: (2020-06-01)

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
by: Chang Ho Ahn, et al.
Published: (2019-05-01)

The inhibition of adenylate kinase by 2,4-thiazolidinedione evaluated by protein-ligand docking
by: Mihaela Ileana Ionescu
Published: (2017-03-01)

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes
by: Iqbal N, et al.
Published: (2014-09-01)

The effect of metformin and thiazolidinedione use on lung cancer in diabetics
by: Mazzone Peter J, et al.
Published: (2012-09-01)

Antidiabetic medications and the risk of prostate cancer in patients with diabetes mellitus: A systematic review and meta-analysis
by: Haiying Cui, et al.
Published: (2022-03-01)

Risk of Parkinson’s Disease (PD) in patients with diabetes using thiazolidinedione (TZD): A systematic review, meta-analysis, and meta-regression
by: Kezia Christy Gunawan, et al.
Published: (2023-09-01)

Correlation between <i>PPARG</i> Pro12Ala Polymorphism and Therapeutic Responses to Thiazolidinediones in Patients with Type 2 Diabetes: A Meta-Analysis
by: Eun Jeong Jang, et al.
Published: (2023-06-01)

Thiazolidinedione Derivatives: In Silico, In Vitro, In Vivo, Antioxidant and Anti-Diabetic Evaluation
by: Manal Y. Sameeh, et al.
Published: (2022-01-01)

Insulin resistance syndrome: interaction with coagulation and fibrinolysis
by: Swiss Medical Weekly
Published: (2002-05-01)

A study on the short-term effect of cafeteria diet and pioglitazone on insulin resistance and serum levels of adiponectin and ghrelin
by: G. Colombo, et al.
Published: (2012-10-01)

The Effects of Pioglitazone on Respiratory Function Test in Patients with Asthma and Type 2 Diabetes Mellitus- A before –after Study
by: Reyhaneh Azizi, et al.
Published: (2019-12-01)

A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis
by: Marina Kawaguchi-Suzuki, et al.
Published: (2018-07-01)

Biological potential of thiazolidinedione derivatives of synthetic origin
by: Sucheta, et al.
Published: (2017-12-01)

Hypoglycemic agents and potential anti-inflammatory activity
by: Kothari V, et al.
Published: (2016-04-01)

The Efficacy of Treatment Intensification by Quadruple Oral Therapy Compared to GLP-1RA Therapy in Poorly Controlled Type 2 Diabetes Mellitus Patients: A Real-world Data Study
by: Minyoung Kim, et al.
Published: (2023-01-01)

Comparison of Natural Course between Thyroid Cancer Nodules and Thyroid Benign Nodules
by: Kyun-Jin Yun, et al.
Published: (2019-06-01)

Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
by: Mohamed Abu-Farha, et al.
Published: (2022-09-01)

Corrosion Inhibition Properties of Thiazolidinedione Derivatives for Copper in 3.5 wt.% NaCl Medium
by: Hassane Lgaz, et al.
Published: (2021-11-01)